Viewing Study NCT01122251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-05-25 @ 2:02 PM
Study NCT ID: NCT01122251
Status: COMPLETED
Last Update Posted: 2011-02-18
First Post: 2010-05-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Sponsor: LG Life Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Essential Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hypertension View
None lercanidipine View
None valsartan View